ChemLifeIntel
CHEMICAL & LIFE SCIENCES INTELLIGENCE
Access

ARTIFICIAL TEARS

TRACKED

CASHSN
THERAPEUTIC AREAS
MOLECULE INTELLIGENCE SNAPSHOTlive
0
Manufacturers monitored
2
Intelligence briefs
2
Active regulatory actions
0
HSN codes

INTELLIGENCE

Showing 2 of 2 briefs for ARTIFICIAL TEARS
REGULATORY INTELLIGENCE·Recall

FDA Class II Recall: Preferred Pharmaceuticals' Artificial Tears Face Sterility Assurance Breach

Preferred Pharmaceuticals Inc. has initiated a nationwide Class II recall (D-0443-2026) for 720 bottles of Artificial Tears Lubricant Eye Drops, manufactured by Geri-Care, due to a lack of sterility assurance. This event highlights critical supply chain and regulatory risks for procurement and quality assurance teams sourcing ophthalmic products, necessitating immediate review of supplier qualification and quality control protocols to mitigate potential patient safety issues and market disruptions.

90-Day Activity
MKMeera Krishnan· Senior Regulatory Intelligence Analyst
2026-04-15 Recall
REGULATORY INTELLIGENCE·Recall

K.C. Pharmaceuticals Recalls 589,848 Artificial Tears Bottles Over Sterility Concerns, Impacting Major US Brands

K.C. Pharmaceuticals, Inc. has initiated a Class II recall for 589,848 bottles of Artificial Tears Sterile Lubricant Eye Drops due to a critical "Lack of Assurance of Sterility." This nationwide U.S. recall, affecting multiple major brands including Leader and Good Sense, demands immediate action from procurement and supply chain leaders. Businesses must assess their exposure to K.C. Pharmaceuticals, Inc. and expedite qualification of alternative ophthalmic product manufacturers to mitigate supply disruption and patient safety risks.

90-Day Activity
CMCatherine Morrow· Senior Regulatory Intelligence Analyst
2026-04-08 Recall